Left Ventricular Systolic Dysfunction clinical trials

Explore recruiting left ventricular systolic dysfunction clinical trials.

Recruiting left ventricular systolic dysfunction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Left Ventricular Systolic Dysfunction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to evaluate Efficacy and Safety of Empagliflozin in the prevention of Cardiotoxicity in Cancer patients undergoing Chemotherapy based on Anthracyclines (EMPACT study)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

(21467) A Phase 3, single-arm, open-label extension study to evaluate the safety of finerenone in addition to standard of care, in pediatric heart failure patients, from birth to 18 years of age, with left ventricular systolic dysfunction (LVSD)

Czechia, Germany, Greece, Italy, Finland, Bulgaria +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Single-arm, Open-label Extension of the Vericiguat VALOR Study in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR EXT)

Italy, Portugal, Sweden, Denmark, Poland, Belgium +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

(14308) Randomized, double-blind, placebo-controlled, parallel-group, multi-center study to evaluate the hemodynamic effects of Riociguat (BAY 63-2521) as well as safety and kinetics in patients with pulmonary hypertension associated with left ventricular systolic dysfunction.

Italy, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

(21466) A multicenter, randomized, double-blind, placebo-controlled, Phase 3 study to investigate the efficacy, safety, and PK/ PD of finerenone, in addition to standard-of-care, in pediatric patients, 6 months to < 18 years of age, with heart failure (HF) and left ventricular systolic dysfunction (LVSD)

Czechia, Poland, Portugal, Austria, Finland, Greece +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR)

Netherlands, Hungary, Portugal, France, Denmark, Spain +8 more

Phase II and Phase III (Integrated) EU CTIS Study details

Left Ventricular Systolic Dysfunction trials by city

Left Ventricular Systolic Dysfunction in Toronto Left Ventricular Systolic Dysfunction in Vancouver Left Ventricular Systolic Dysfunction in Montreal Left Ventricular Systolic Dysfunction in Calgary Left Ventricular Systolic Dysfunction in Edmonton Left Ventricular Systolic Dysfunction in Ottawa Left Ventricular Systolic Dysfunction in Winnipeg Left Ventricular Systolic Dysfunction in Quebec City Left Ventricular Systolic Dysfunction in Hamilton Left Ventricular Systolic Dysfunction in Kitchener Left Ventricular Systolic Dysfunction in London Left Ventricular Systolic Dysfunction in Halifax Left Ventricular Systolic Dysfunction in New York Left Ventricular Systolic Dysfunction in Los Angeles Left Ventricular Systolic Dysfunction in Chicago Left Ventricular Systolic Dysfunction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease